Head of Endocrinology and Metabology Service
Ludwig-Maximilians University, Germany
Martin Bidlingmaier is an MD and graduated from medical school in Munich, Germany, in 1993. Since then he has risen through the ranks at Munich University hospitals and got training in Internal Medicine, Endocrinology, Clinical Chemistry and Microbiology. Since 2003 Dr. Bidlingmaier is head of the Endocrine Laboratories and leads the Neuroendocrine Research Group at the Department of Internal Medicine.
His research interests include development and validation of laboratory methods for pituitary and adrenal hormones, clinical applications and biochemical monitoring of growth hormone (GH), physiology and pathophysiology of GH and its isoforms and endocrine aspects of doping in sports.
Dr Bidlingmaier is a member of various national and international associations such as the German, the European and the US Endocrine Society. In 2014 he was appointed secretary of the Growth Hormone Research Society (GRS), He also chairs the Sections for Endocrine Laboratory Diagnostics of the German Endocrine Society (DGE) and the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) and is scientific advisor of the German Reference Institute for Bioanalytics (RfB). Between 2011 and 2019, he served as a member of the World Anti-doping Agencies (WADA) Prohibited List Expert Group. He is also a member of the German National Anti-Doping Agencies (NADA) Commission for the Doping Control System.
Dr. Bidlingmaier is author of more than 300 articles in peer-reviewed journals (h-index 55), and serves on the editorial board of several journals.
View full disclosure information